A novel neuroprotective therapy for Parkinson’s disease using a viral noncoding RNA that protects mitochondrial complex I activity

Wei-Li Kuan, Emma Poole, Michael Fletcher, Sharon Karniely, Pam Tyers, Mark Wills, Roger A Barker, John H Sinclair
J. Exp. Med. Jan 16, 2012
… glucose, and 1 mM kynurenic acid). Mitochondrial preparations were obtained from brain sections using a proprietary mitochondria isolation kit (BioChain Institute) as described by the manufacturer. For analysis of Complex I …

Leave a Reply